Lysinuric protein intolerance: identification and functional analysis of mutations of the SLC7A7 gene
- PMID: 15776427
- DOI: 10.1002/humu.9323
Lysinuric protein intolerance: identification and functional analysis of mutations of the SLC7A7 gene
Abstract
Lysinuric protein intolerance (LPI) is an inherited hyperdibasic aminoaciduria caused by defective cationic amino acid (CAA) transport at the basolateral membrane of epithelial cells in the intestine and kidney. LPI is relatively common in Finland and a few clusters of patients are known in Italy and Japan. The SLC7A7 gene, mutated in LPI patients, encodes the y+LAT-1 protein which is the light subunit of a heterodimeric CAA transporter. We performed the mutation analysis in seven probands from five unrelated LPI families and identified five novel SLC7A7 mutations (p.M50K, p.T188I, p.R333M, p.Y457X, and c.499+?_629-?). By expression studies in X. laevis oocytes or patient's renal tubular cells, the functional analysis of altogether eight SLC7A7 mutations is here reported. Noteworthy, the p.R333M mutation, caused by a G to T transversion of the last nucleotide at 3' end of exon 7, disrupts a functional splicing motif generating misspliced transcripts. Three of the novel mutations were found in patients originating from Greece and Pakistan thus increasing the list of ethnic backgrounds where LPI mutant alleles are present. This reinforces the view that the rarity of LPI outside Finland might be ascribed to misdiagnosis of this disease.
Similar articles
-
Lysinuric protein intolerance: update and extended mutation analysis of the SLC7A7 gene.Hum Mutat. 2008 Jan;29(1):14-21. doi: 10.1002/humu.20589. Hum Mutat. 2008. PMID: 17764084 Review.
-
Five novel SLC7A7 variants and y+L gene-expression pattern in cultured lymphoblasts from Japanese patients with lysinuric protein intolerance.Hum Mutat. 2002 Nov;20(5):375-81. doi: 10.1002/humu.10140. Hum Mutat. 2002. PMID: 12402335
-
SLC7A7 genomic structure and novel variants in three Japanese lysinuric protein intolerance families.Hum Mutat. 2000;15(4):367-72. doi: 10.1002/(SICI)1098-1004(200004)15:4<367::AID-HUMU9>3.0.CO;2-C. Hum Mutat. 2000. PMID: 10737982
-
Two alternative promoters regulate the expression of lysinuric protein intolerance gene SLC7A7.Mol Genet Metab. 2007 Mar;90(3):298-306. doi: 10.1016/j.ymgme.2006.11.007. Epub 2006 Dec 29. Mol Genet Metab. 2007. PMID: 17196863
-
Lysinuric protein intolerance: reviewing concepts on a multisystem disease.Am J Med Genet C Semin Med Genet. 2011 Feb 15;157C(1):54-62. doi: 10.1002/ajmg.c.30287. Epub 2011 Feb 9. Am J Med Genet C Semin Med Genet. 2011. PMID: 21308987 Review.
Cited by
-
Structural basis for the substrate recognition and transport mechanism of the human y+LAT1-4F2hc transporter complex.Sci Adv. 2025 Mar 21;11(12):eadq0558. doi: 10.1126/sciadv.adq0558. Epub 2025 Mar 19. Sci Adv. 2025. PMID: 40106545 Free PMC article.
-
In Lysinuric Protein Intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages.Orphanet J Rare Dis. 2010 Nov 26;5:32. doi: 10.1186/1750-1172-5-32. Orphanet J Rare Dis. 2010. PMID: 21110863 Free PMC article.
-
Outcomes of kidney transplantation in patients with lysinuric protein intolerance.Clin Kidney J. 2024 Nov 22;18(1):sfae373. doi: 10.1093/ckj/sfae373. eCollection 2025 Jan. Clin Kidney J. 2024. PMID: 39802587 Free PMC article.
-
Heteromeric Amino Acid Transporters in Brain: from Physiology to Pathology.Neurochem Res. 2022 Jan;47(1):23-36. doi: 10.1007/s11064-021-03261-w. Epub 2021 Feb 19. Neurochem Res. 2022. PMID: 33606172 Review.
-
Inducible Slc7a7 Knockout Mouse Model Recapitulates Lysinuric Protein Intolerance Disease.Int J Mol Sci. 2019 Oct 24;20(21):5294. doi: 10.3390/ijms20215294. Int J Mol Sci. 2019. PMID: 31653080 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials